ADAMTS13 activity, in sickle cell disease: A role in the development of clinical vaso-occlusion?

被引：0
|
作者：
Schnog, JJB
Kremer-Hovinga, J
Akin, S
Ozveren, E
Krieg, S
Lammle, B
Brandjes, D
MacGillavry, MR
Muskiet, FD
Duits, AJ
机构：
[1] Slotervaart Hosp, Amsterdam, Netherlands
[2] Red Cross Blood Bank Fdn, Curacao, Neth Antilles
[3] Univ Hosp, Hemostasis Res Lab, Bern, Switzerland
[4] Erasmus Med Ctr, Rotterdam, Netherlands
[5] St Elizabeth Hosp, Curacao, Neth Antilles
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.3738.3738
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3738
引用
收藏
页码：21B / 21B
页数：1
相关论文
共 50 条
  • [31] VASO-OCCLUSION IN SICKLE-CELL DISEASE - PATHO-PHYSIOLOGY OF THE MICROVASCULAR CIRCULATION
    KURANTSINMILLS, J
    KLUG, PP
    LESSIN, LS
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1988, 10 (04): : 357 - 372
  • [32] ADAMTS13 antigen, activity, autoantibody and ADAMTS13/fXI complex levels may be useful diagnostic biomarkers for patients with sickle cell disease
    Fryer, Hugh J. L.
    Grafos, Nicholas
    Guinto, Enriqueta R.
    Wu, Jogin
    Bai, Bing
    Greenfield, Robert S.
    BLOOD, 2007, 110 (11) : 18B - 19B
  • [33] Oxidative stress and vaso-occlusion in sickle cell disease: Role of activated leukocytes and redox active iron.
    Belcher, JD
    Mahaseth, H
    Welch, TE
    Boakye-Agyeman, F
    Hebbel, RP
    Vercellotti, GM
    BLOOD, 2005, 106 (11) : 884A - 884A
  • [34] Targeting ICAM1 to Ameliorate Vaso-Occlusion and Inflammation in Sickle Cell Disease
    Gupta, Parul
    Kumar, Ravindra
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (06) : 730 - 737
  • [35] A rat model for sickle cell-mediated vaso-occlusion in retina
    Lutty, GA
    Phelan, A
    McLeod, DS
    Fabry, ME
    Nagel, RL
    MICROVASCULAR RESEARCH, 1996, 52 (03) : 270 - 280
  • [36] Heme oxygenase-1: A potential modulator of inflammation and vaso-occlusion in sickle cell disease
    Belcher, JD
    Welch, TE
    Mahaseth, H
    Sonbol, KM
    Bowlin, PR
    Bischof, JC
    Hebbel, RP
    Vercellotti, GM
    BLOOD, 2004, 104 (11) : 107A - 108A
  • [37] No Evidence for Cell Activation or Vaso-Occlusion with Plerixafor Treatment of Sickle Cell Mice
    Choi, Erika
    Cui, Min-Hui
    Mohandas, Narla
    Yazdanbakhsh, Karina
    Billett, Henny Heisler
    Branch, Craig A.
    Shi, Patricia A.
    BLOOD, 2015, 126 (23)
  • [38] Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli
    Bennewitz, Margaret F.
    Jimenez, Maritza A.
    Vats, Ravi
    Tutuncuoglu, Egemen
    Jonassaint, Jude
    Kato, Gregory J.
    Gladwin, Mark T.
    Sundd, Prithu
    JCI INSIGHT, 2017, 2 (01):
  • [39] HLA class II haplotypes distinctly associated with vaso-occlusion in children with sickle cell disease
    Mahdi, Najat
    Al-Ola, Khadija
    Al-Subaie, Abeer M.
    Ali, Muhallab E.
    Al-Irhayim, Zaid
    Al-Irhayim, A. Qader
    Almawi, Wassim Y.
    CLINICAL AND VACCINE IMMUNOLOGY, 2008, 15 (04) : 729 - 731
  • [40] Erythrocytes from Sickle Cell Mice Activate the Endothelium and Blood Cells and Induce Vaso-Occlusion When Transfused into ADAMTS13-Deficient Mice: Role of Lipid Degradation
    Adili, Reheman
    Chen, Junmei
    Roads, Nicole
    Maldonado, Richard
    Lazaro, Hallie
    Chung, Dominic W.
    Fu, Xiaoyun
    Lopez, Jose A.
    BLOOD, 2024, 144 : 3864 - 3865
12345